OrthoPediatrics Corp.

OrthoPediatrics is a medical device company exclusively focused on orthopedic implants and bracing for children — the only pure-play pediatric orthopedics MedTech. Its 100-point trial score spans 5 Phase 1, 11 Phase 2, and 10 Phase 3 studies. Only 5 insider transactions, but OrthoPediatrics' niche market exclusivity in pediatric orthopedic devices, recurring surgical implant revenue, and international expansion story make it a durable small-cap MedTech compounder.

<article class="bts-verified-summary" data-ticker="KIDS">
<p>OrthoPediatrics Corp. Common Stock (KIDS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>KIDS has 5 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001425450 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22KIDS%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>